Oric Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Oric Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2021 to Q4 2023.
  • Oric Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $9.14M, a 16.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $9.14M -$1.84M -16.8% Dec 31, 2023 10-K 2024-03-11
Q4 2022 $11M -$812K -6.88% Dec 31, 2022 10-K 2024-03-11
Q4 2021 $11.8M Dec 31, 2021 10-K 2023-03-16
Q3 2021 $12M Sep 30, 2021 10-Q 2021-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.